Suppression of cell-transferred experimental autoimmune encephalomyelitis in defibrinated Lewis rats
暂无分享,去创建一个
[1] N. Egberg. Coagulation studies in patients treated with defibrase. , 2009, Acta medica Scandinavica.
[2] T. Johns,et al. Myelin oligodendrocyte glycoprotein induces a demyelinating encephalomyelitis resembling multiple sclerosis. , 1995, Journal of immunology.
[3] A. Ben-nun,et al. Chronic relapsing experimental autoimmune encephalomyelitis with a delayed onset and an atypical clinical course, induced in PL/J mice by myelin oligodendrocyte glycoprotein (MOG)‐derived peptide: Preliminary analysis of MOG T cell epitopes , 1995, European journal of immunology.
[4] S. Miller,et al. The immunopathogenesis and regulation of T-cell-mediated demyelinating diseases. , 1994, Immunology today.
[5] C. Koh,et al. Neurovascular permeability and fibrin deposition in the central neuraxis of Lewis rats with cell-transferred experimental allergic encephalomyelitis in relationship to clinical and histopathological features of the disease , 1993, Journal of Neuroimmunology.
[6] S. Miller,et al. Induction of active and adoptive relapsing experimental autoimmune encephalomyelitis (EAE) using an encephalitogenic epitope of proteolipid protein , 1992, Journal of Neuroimmunology.
[7] C. Koh,et al. Concordance and localization of maximal vascular permeability change and fibrin deposition in the central neuraxis of Lewis rats with cell-transferred experimental allergic encephalomyelitis , 1992, Journal of Neuroimmunology.
[8] H. Kwaan,et al. Neurovascular fibrinolytic activity in normal Lewis rats and rats with cell-transferred experimental allergic encephalomyelitis , 1990, Journal of Neuroimmunology.
[9] R. Sobel,et al. Identification of an encephalitogenic determinant of myelin proteolipid protein for SJL mice. , 1989, Journal of immunology.
[10] H. Clark,et al. Myelin proteolipid protein induces demyelinating disease in mice , 1987, Journal of the Neurological Sciences.
[11] C. Koh,et al. Suppression of clinical signs of cell-transferred experimental allergic encephalomyelitis and altered cerebrovascular permeability in Lewis rats treated with a plasminogen activator inhibitor. , 1987, Cellular immunology.
[12] R. Poston,et al. Inflammatory vasculitis in multiple sclerosis , 1985, Journal of the Neurological Sciences.
[13] C. Geczy,et al. Susceptibility and resistance to experimental autoimmune encephalomyelitis and neuritis in the guinea pig correlate with the induction of procoagulant and anticoagulant activities. , 1984, Journal of immunology.
[14] O. Paulson,et al. Blood-brain and blood-spinal cord barrier permeability during the course of experimental allergic encephalomyelitis in the rat , 1984, Brain Research.
[15] D. McFarlin,et al. Induction of experimental allergic encephalomyelitis in PL/J and (SJL/J x PL/J)F1 mice by myelin basic protein and its peptides: localization of a second encephalitogenic determinant. , 1983, Journal of immunology.
[16] Paterson Py. Molecular and cellular determinants of neuroimmunologic inflammatory disease. , 1982 .
[17] S. Levine,et al. Localization of toxic encephalopathies near lesions of experimental allergic encephalomyelitis. , 1982, The American journal of pathology.
[18] D. McFarlin,et al. Chronologic neuropathology of relapsing experimental allergic encephalomyelitis in the mouse. , 1982, Laboratory investigation; a journal of technical methods and pathology.
[19] C. Pettinelli,et al. Adoptive transfer of experimental allergic encephalomyelitis in SJL/J mice after in vitro activation of lymph node cells by myelin basic protein: requirement for Lyt 1+ 2- T lymphocytes. , 1981, Journal of immunology.
[20] Brown Am,et al. Relapsing experimental allergic encephalomyelitis in the SJL/J mouse. , 1981, Laboratory investigation; a journal of technical methods and pathology.
[21] D. Lane. FIBRINOGEN DERIVATIVES IN PLASMA , 1981, British journal of haematology.
[22] K. Sueishi,et al. Permeability Enhancing and Chemotactic Activities of Lower Molecular Weight Degradation Products of Human Fibrinogen , 1981, Thrombosis and Haemostasis.
[23] T. Saldeen,et al. Effect of fibrin degradation products on microvascular permeability. , 1978, Thrombosis research.
[24] Paterson Py. Experimental allergic encephalomyelitis: role of fibrin deposition in immunopathogenesis of inflammation in rats. , 1976, Federation proceedings.
[25] J. Mcdonagh,et al. Alternative Pathways for the Activation of Factor XIII , 1975, British journal of haematology.
[26] R. Swanborg,et al. Studies on the species-variability of experimental allergic encephalomyelitis in guinea pigs and rats. , 1974, Journal of immunology.
[27] M. Bernik. Increased plasminogen activator (urokinase) in tissue culture after fibrin deposition. , 1973, The Journal of clinical investigation.
[28] J. Mustard,et al. Platelet interaction with polymerizing fibrin. , 1972, The Journal of clinical investigation.
[29] M. Oldstone,et al. Immunohistochemical study of allergic encephalomyelitis. , 1968, The American journal of pathology.
[30] A. Fletcher,et al. Fibrinolytic mechanisms and the development of thrombolytic therapy. , 1962, The American journal of medicine.
[31] P. Y. Paterson. TRANSFER OF ALLERGIC ENCEPHALOMYELITIS IN RATS BY MEANS OF LYMPH NODE CELLS , 1960, The Journal of experimental medicine.
[32] H. Kwaan,et al. On the production of plasma fibrinolytic activity within veins. , 1957, Clinical science.
[33] H. Kwaan,et al. Role of the clotting system in the pathogenesis of neuroimmunologic disease. , 1987, Federation proceedings.
[34] H. Kwaan,et al. The clotting system: gatekeeper of cerebrovascular permeability and monitor of clinical manifestations of neuroautoimmune disease. , 1986, Transactions of the American Clinical and Climatological Association.
[35] S. Gregory,et al. Cellular pathways and signals for the induction of biosynthesis of initiators of the coagulation protease cascade by cells of the monocyte lineage , 1985 .
[36] Smejda Haug Fm. Heavy metals in the brain. A light microscope study of the rat with Timm's sulphide silver method. Methodological considerations and cytological and regional staining patterns. , 1973 .